Side-by-side comparison of AI visibility scores, market position, and capabilities
Clarify Health is an AI-powered healthcare analytics platform serving health plans, providers, and life sciences — raised $150M+ total, acquired Apervita in 2024 to expand value-based care analytics.
Clarify Health is a San Francisco-based cloud analytics company that provides AI-powered performance measurement, benchmarking, and market intelligence to health plans, health systems, and life sciences companies. Its flagship platform, Clarify Atlas, aggregates and analyzes longitudinal patient journey data to deliver insights into provider performance, market dynamics, price transparency, referral patterns, and care quality — enabling payers and providers to manage value-based care arrangements and identify opportunities to improve outcomes while reducing costs.
mRNA pioneer with $3.2B FY2024 revenue (down from $18.4B 2022 COVID peak); mRESVIA RSV vaccine approved 2024; personalized cancer vaccine with Merck shows 44% recurrence reduction in melanoma.
Moderna is a clinical-stage biotechnology company that pioneered the development of messenger RNA (mRNA) therapeutics and vaccines, founded in 2010 by Noubar Afeyan, Robert Langer, Kenneth Chien, Stéphane Bancel, and others in Cambridge, Massachusetts, where it is headquartered and trades on Nasdaq (MRNA). The company achieved extraordinary commercial success with Spikevax, its COVID-19 mRNA vaccine developed in partnership with the U.S. government in 2020—generating $18.4 billion in COVID vaccine revenues in 2022 at peak—before experiencing a severe revenue decline as global COVID booster demand normalized. For FY2024, Moderna generated approximately $3.2 billion in revenues, with Spikevax and the reformulated XBB.1.5-targeting COVID vaccine contributing the majority, while the company's significant R&D investment pipeline consumed most operating cash flows.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.